During the past decade, Mariangela Rondanelli conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mariangela Rondanelli" are "Covid19" (1 trials), "Glucose Metabolism Disorders" (1 trials) and "Postmenopausal Disorder" (1 trials). Many other conditions were trialed in "Mariangela Rondanelli" in a lesser frequency.

Most popular intervention types in "Mariangela Rondanelli" are "Dietary Supplement" (3 trials) and "Combination Product" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Berberine Phytosome" (1 trials), "Camellia Sinensis leaf extract" (1 trials) and "Quercetin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mariangela Rondanelli" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Mariangela Rondanelli". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Mariangela Rondanelli, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mariangela Rondanelli, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".